Standout Papers
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation (2011)
- Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome (2000)
- Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus (2017)
- Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study (2003)
- ACG Clinical Guideline: Management of Irritable Bowel Syndrome (2020)
Immediate Impact
1 by Nobel laureates 26 from Science/Nature 101 standout
Citing Papers
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist
2023 Standout
The microbiome and human cancer
2021 StandoutScience
Works of Mark Pimentel being referenced
Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome
2021
Pathogen-Specific Risk of Celiac Disease Following Bacterial Causes of Foodborne Illness: A Retrospective Cohort Study
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mark Pimentel | 7664 | 4221 | 2901 | 284 | 11.2k | |
| Giovanni Barbara | 8921 | 5578 | 3063 | 272 | 14.6k | |
| Roberto De Giorgio | 9512 | 6920 | 2722 | 429 | 16.7k | |
| Brian E. Lacy | 8499 | 4788 | 2369 | 218 | 11.2k | |
| Michael D. Crowell | 6474 | 4783 | 2894 | 275 | 12.1k | |
| Elena F. Verdú | 6635 | 3747 | 2645 | 218 | 15.6k | |
| Gerald Holtmann | 9055 | 6306 | 2277 | 392 | 13.7k | |
| Kevin Whelan | 4875 | 2707 | 3736 | 273 | 12.9k | |
| Juan‐R. Malagelada | 4526 | 3588 | 2020 | 131 | 9.7k | |
| Peter J. Whorwell | 11768 | 5532 | 3684 | 323 | 17.3k | |
| Fernando Azpiroz | 7707 | 4217 | 3046 | 261 | 11.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...